Dr. Rubin on the Second Annual Sherman Prize for Excellence in Crohn’s and Colitis

David T. Rubin, MD, FACG Recognizing Exceptional and Pioneering Contributions in Crohn’s Disease and Ulcerative Colitis Nominate Your Peers by April 30 at ShermanPrize.org  By David T. Rubin, MD, FACG, ACG Board of Trustees, Chair, Sherman ...

Sherman Prize Honors Excellence in IBD

Sherman Prize Honors Excellence in Crohn’s and Colitis by Sunanda V. Kane, MD, FACG This week, the recipients of the inaugural Sherman Prize were announced. As a member of the Prize Selection Committee, I am proud to share this news with ...

“Enter the Biosimilars”: An ACG-CCFA Webinar with Dr. David T. Rubin

ACG and CCFA Co-Hosted an IBD Circle Webinar Optimizing Medical Therapy in IBD: Enter the Biosimilars June 29, 2016 David T. Rubin, MD, FACG You can listen this webinar with David T. Rubin, MD, FACG who shares insights on how clinicians ...

A Randomized, Double-Blind, Placebo-Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Results of the Maintenance Period of the TOUCHSTONE Study

  Stephen B. Hanauer, MD, FACG Oral 19 A Randomized, Double-Blind, Placebo-Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Results of the Maintenance Period of the TOUCHSTONE Study Author ...

Now Available: New ACG Ulcerative Colitis Guidebook & Video for Your Patients

A new guidebook and video is now available from the American College of Gastroenterology to help patients understand that ulcerative colitis (UC) is a treatable condition that can be managed effectively. This valuable resource is designed for ...

What an “IBD-ologist” Learned at DDW

Stephen B. Hanauer, MD, FACG I remain an IBD-ologist and at DDW I tend to focus on advances in our field. So, what did I learn? IBD causation is not simple or easy (yet). There is a spectrum of complexity between gene and environmental interactions. ...